pathologic nystagmus |
Disease ID | 1349 |
---|---|
Disease | pathologic nystagmus |
Integrated Phenotype | (Waiting for update.) |
Text Mined Phenotype | (Waiting for update.) |
Disease ID | 1349 |
---|---|
Disease | pathologic nystagmus |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:2) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs121908212 | 18670797 | 773 | CACNA1A | umls:C0028738 | BeFree | Although clinical features associated with the T666M CACNA1A mutation are highly variable, downbeat positioning nystagmus may be an important clinical feature of this disease. | 0.002171535 | 2008 | CACNA1A | 19 | 13303877 | G | A |
rs137852212 | 17962394 | 90167 | FRMD7 | umls:C0028738 | BeFree | A novel p.R229G mutation in the FRMD7 gene causes the NYS phenotype, and skewed X inactivation influences the manifestation of the disease in X linked NYS females. | 0.005624334 | 2008 | FRMD7 | X | 132084546 | G | C |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:17) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0028738 | baclofen | D001418 | 1134-47-0 | nystagmus, pathologic | MESH:D009759 | therapeutic | 11096749 | ||
C0028738 | carbamazepine | D002220 | 298-46-4 | nystagmus, pathologic | MESH:D009759 | marker/mechanism | 4049464 | ||
C0028738 | celecoxib | D000068579 | - | nystagmus, pathologic | MESH:D009759 | marker/mechanism | 12380707 | ||
C0028738 | digoxin | D004077 | 20830-75-5 | nystagmus, pathologic | MESH:D009759 | marker/mechanism | 5440585 | ||
C0028738 | ethchlorvynol | D004984 | 113-18-8 | nystagmus, pathologic | MESH:D009759 | marker/mechanism | 1173627 | ||
C0028738 | fluoxetine | D005473 | 54910-89-3 | nystagmus, pathologic | MESH:D009759 | marker/mechanism | 7806697 | ||
C0028738 | gabapentin | C040029 | 60142-96-3 | nystagmus, pathologic | MESH:D009759 | therapeutic | 11096749 | ||
C0028738 | lidocaine | D008012 | 137-58-6 | nystagmus, pathologic | MESH:D009759 | marker/mechanism | 4713141 | ||
C0028738 | mefloquine | D015767 | 53230-10-7 | nystagmus, pathologic | MESH:D009759 | marker/mechanism | 12879977 | ||
C0028738 | metformin | D008687 | 657-24-9 | nystagmus, pathologic | MESH:D009759 | marker/mechanism | 14984458 | ||
C0028738 | methotrexate | D008727 | 1959/5/2 | nystagmus, pathologic | MESH:D009759 | marker/mechanism | 8638223 | ||
C0028738 | morphine | D009020 | 57-27-2 | nystagmus, pathologic | MESH:D009759 | marker/mechanism | 10960401 | ||
C0028738 | nicotine | D009538 | - | nystagmus, pathologic | MESH:D009759 | marker/mechanism | 11094116 | ||
C0028738 | pentobarbital | D010424 | 76-74-4 | nystagmus, pathologic | MESH:D009759 | marker/mechanism | 1155542 | ||
C0028738 | phenytoin | D010672 | 57-41-0 | nystagmus, pathologic | MESH:D009759 | marker/mechanism | 109744 | ||
C0028738 | tacrolimus | D016559 | 109581-93-3 | nystagmus, pathologic | MESH:D009759 | marker/mechanism | 10954277 | ||
C0028738 | valproic acid | D014635 | 99-66-1 | nystagmus, pathologic | MESH:D009759 | therapeutic | 3137915 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |